Forty years of human G-CSF: A short history in time

被引：2
作者：
Welte, Karl [1 ]
机构：
[1] Univ Childrens Hosp, Tubingen, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2024年 / 205卷 / 04期
关键词：
G-CSF; recombinant G-CSF; Filgrastim; Lenograstim; congenital neutropenia; chemotherapy induced neutropenia; COLONY-STIMULATING FACTOR; CELLS; NEUTROPENIA; PURIFICATION;
D O I：
10.1111/bjh.19713
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Human G-CSF was identified in 1984 at Memorial Sloan-Kettering Cancer Centre, New York. Based on these findings, recombinant G-CSF was developed by Amgen, Thousand Oaks. In 1987, clinical trials began using recombinant G-CSF in cancer patients following chemotherapy to reduce the duration of neutropenia and in patients with congenital neutropenia (CN) to increase the number of neutrophils. It has changed the quality of life for many cancer patients and saved the lives of many patients with (CN).
引用
收藏
页码：1296 / 1298
页数：3
相关论文
共 50 条
  • [1] Neutropenia and G-CSF in lymphoproliferative diseases
    Ria, Roberto
    Reale, Antonia
    Moschetta, Michele
    Dammacco, Franco
    Vacca, Angelo
    HEMATOLOGY, 2013, 18 (03) : 131 - 137
  • [2] New G-CSF agonists for neutropenia therapy
    Hoggatt, Jonathan
    Pelus, Louis M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (01) : 21 - 35
  • [3] Application of G-CSF in Congestive Heart Failure Treatment
    Pourtaji, Atena
    Jahani, Vajiheh
    Moallem, Seyed Mohammad Hassan
    Karimani, Asieh
    Mohammadpour, Amir Hooshang
    CURRENT CARDIOLOGY REVIEWS, 2019, 15 (02) : 83 - 90
  • [4] Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF
    Ozcelik, T.
    Topcuoglu, P.
    Beksac, M.
    Ozcan, M.
    Arat, M.
    Biyikli, Z.
    Bakanay, S. M.
    Ilhan, O.
    Gurman, G.
    Arslan, O.
    Demirer, T.
    BONE MARROW TRANSPLANTATION, 2009, 44 (12) : 779 - 783
  • [5] G-CSF: filgrastim, lenograstim and biosimilars
    Welte, Karl
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (07) : 983 - 993
  • [6] Human G-CSF synthesis using stress-responsive bacterial proteins
    Song, Jong-Am
    Han, Kyung-Yeon
    Park, Jin-Seung
    Seo, Hyuk-Seong
    Ahn, Keum-Young
    Lee, Jeewon
    FEMS MICROBIOLOGY LETTERS, 2009, 296 (01) : 60 - 66
  • [7] G-CSF, the guardian of granulopoiesis
    Mehta, Hrishikesh M.
    Corey, Seth J.
    SEMINARS IN IMMUNOLOGY, 2021, 54
  • [8] Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia
    Basnett, Jordan
    Xie, Vicki
    Cisterne, Adam
    Bradstock, Ken
    Bendall, Linda
    PLOS ONE, 2017, 12 (11):
  • [9] Expression and one step intein-mediated purification of biologically active human G-CSF in Escherichia coli
    Sima, Setareh
    Shafiee, Fatemeh
    Jahanian-Najafabadi, Ali
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (04) : 2861 - 2869
  • [10] Molecular Cloning, Expression and Purification of G-CSF Isoform D, an Alternative Splice Variant of Human G-CSF
    Toghraie, Fatemeh Sadat
    Yazdanpanah-Samani, Mahsa
    Maymand, Elham Mahmoudi
    Hosseini, Ahmad
    Asgari, Amir
    Ramezani, Amin
    Ghaderi, Abbas
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2019, 18 (04) : 419 - 426
12345